The partnership will evaluate sustained delivery of Rallybio’s inhibitor of complement component 5 (C5) using EyePoint’s proprietary Durasert technology for sustained intraocular drug delivery. The initial focus will be on geographic atrophy, an advanced form of age-related macular degeneration that leads to irreversible vision loss.
Biden Administration Official, Often Criticized For Big-Tech Ties, Met With Tim Cook, Andy Jassy In April 2021: Report
U.S. Commerce Secretary Gina Raimondo had meetings with high-profile corporate tech chiefs, including Apple, Inc.
